KeraStat® Cream Cleared by FDA for Radiation Dermatitis

Winston-Salem, N.C., July 20, 2020 – KeraNetics Inc. announces today that the next product in its KeraStat® wound dressing portfolio, KeraStat® Cream, has been cleared by the US Food and Drug Administration for indications of radiation dermatitis. This product is...

KeraNetics™ Receives FDA Clearance for KeraStat®Gel

Winston-Salem, NC, June 2, 2017 – KeraNetics, LLC, the global leader in purified keratin medical products, announced today that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for KeraStat® Gel.  KeraStat® Gel is a hydrogel wound...